| Metrics | Details |
|---|---|
| Years | 2020-2035 |
| Base Year | 2025 |
| Market Size | 2600 |
| Regions | US, Canada, Mexico |
| Segments | By Type (Allogeneic, Autologous, Viral Vector, Non-viral Vector, Plasmid DNA, Others); By Application (Oncology, Cardiovascular Diseases, Neurological Disorders, Rare Diseases, Infectious Diseases, Others); By Technology (Gene Editing, Cell Expansion, Viral Vector Production, Cryopreservation, Automation, Others); By Distribution Channels (Direct Tenders, Third-Party Distributors, Online Platforms, Hospital Pharmacies, Retail Pharmacies, Others); By Organization Size (Small, Medium, Large) |
| Players | Thermo Fisher Scientific, Lonza, Catalent, WuXi AppTec, Charles River Laboratories, Oxford Biomedica, Samsung Biologics, FUJIFILM Diosynth Biotechnologies, Bluebird Bio, Cell and Gene Therapy Catapult, uniQure, Novartis, BioNTech, Bristol Myers Squibb, Editas Medicine |
How Will You Befit From our consulting service
